Search is Powered by Google
HIV / AIDS News

Washington, D.C., To Invest $650,000 In Needle-Exchange Programs

Main Category: HIV / AIDS
Also Included In: Alcohol / Addiction / Illegal Drugs
Article Date: 04 Jan 2008 - 11:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:5 stars

5 (1 votes)

Health Professional:3 stars

3 (1 votes)

Article Opinions: 1 posts

Washington, D.C., plans to invest $650,000 in needle-exchange programs to help prevent the spread of HIV among injection drug users in the city, officials announced Wednesday, the Washington Post reports (Nakamura, Washington Post, 1/3). The announcement comes after President Bush last week signed a $555 billion fiscal year 2008 omnibus spending bill (HR 2764) that effectively lifts a ban on city funding for needle-exchange programs in the district. Since 1999, the district has been the only U.S. city barred by federal law from using local funds for needle-exchange programs. A report released in November by district health officials found that injection drug use was the second most common cause of HIV transmission in the city (Kaiser Daily HIV/AIDS Report, 1/2).

"This program goes to best practices to combat one of our greatest health problems," district Mayor Adrian Fenty said at a news conference at the headquarters of PreventionWorks!, which operates the district's only needle-exchange program. PreventionWorks! will receive a $300,000 city grant, and the remaining $350,000 will go toward creating new needle-exchange programs, Fenty said. Ken Vail of PreventionWorks! said that the organization serves about 2,000 people at 12 locations in the city and that it exchanged 200,000 needles last year.

Del. Eleanor Holmes Norton (D-D.C.) in a statement said, "The district's AIDS rate is artificially elevated" because of the former funding ban, adding, "Now we have a lot of catching up to do." Council member David Catania, chair of the Committee on Health, said the public investment will be cost-effective in the long term if the exchange programs are successful. "The cost of infection is immeasurably higher [then needle-exchange programs] in terms of dollars and lives," he added. Shannon Hader, head of the district's HIV/AIDS Administration, said she expects the city to establish a variety of new needle-exchange programs, such as mobile clinics, outreach initiatives and fixed-site programs. Fenty said everyone should "be concerned" about HIV/AIDS when asked how he would respond to residents who might object to having needle-exchange programs in their neighborhoods (Washington Post, 1/3). "HIV and AIDS are such well-known public health problems in the District of Columbia that people understand we have to have programs and services in the neighborhoods," he added (AP/International Herald Tribune, 1/3).

Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation© 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.




Customized Homepage Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar Diabetes Schizophrenia

add medical news today to your facebook

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


MedReader RSS Reader

customize your homepage


These are the most read articles from this news category for the last 6 months:
Top Article Star
FDA To Recommend That Doctors Conduct Genetic Screening Before Prescribing Antiretroviral Abacavir To Reduce Allergic Reactions
25 Jul 2008
FDA on Thursday is expected to issue an advisory that urges physicians to conduct genetic testing before prescribing GlaxoSmithKline's antiretroviral drug abacavir to reduce allergic reactions in people taking the drug, the...


Talking with Your Doctor image Talking with Your Doctor

Talking with your doctor can sometimes be difficult. Good health care, however, depends on an open dialogue between patients and doctors...

Keeping a Personal Medical Record image Keeping a Personal Medical Record

Medical information is usually scattered in many different places. To receive the best possible health care, people are encouraged to gather information in one place and create a personal medical record...

View more videos...